Dr Reddys Laboratories Share Price

Dr Reddys Labs

CMP as on 20-May-22 15:52

₹ 4,249.10
319.65 8.13%

Open

₹ 3,975.00

Turnover (lac)

₹ 1,05,391

Prev. Close

₹ 3,929.45

Day's Vol (shares)

₹ 24,80,315

Day's Range (₹)

₹ 3,975.00
₹ 4,299.10

CMP as on20-May-22 15:59

₹ 4,246.30
318.25 8.1%

Open

₹ 3,984.00

Turnover (lac)

₹ 516

Prev. Close

₹ 3,928.05

Day's Vol (shares)

₹ 69,153

Day's Range

₹ 3,982.85
₹ 4,299.00

CMP as on 20-May-22 0:00

₹ 4,228.05
294.75 7.49%

Open

₹ 3,985.00

Open Interest(Contracts)

₹ 23,55,750

VWAP

₹ 4,176.05

Day's Vol (shares)

₹ 25,26,125

Day's Range (Ex.Dt. 26 May 2022)

₹ 3,985.00
₹ 4,297.90

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 29-Mar-2022 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2022 inter alia to consider and approve to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ending on March 31 2022 and to recommend dividend if any for the financial year 2021-22. Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 19, 2022, inter alia, has recommended a final dividend of Rs. 30/- (600%) per equity share of Rs. 5/- each for the financial year 2021-22. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 38th Annual General Meeting (AGM). (As Per BSE Announcement Dated on 19.05.2022)
Board Meeting - 22-Apr-2022 - -
Intimation of allotment, pursuant to merger
Board Meeting - 28-Dec-2021 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve Unaudited Financial Results of the Company for the quarter and nine months ending on December 31 2021 among other things Outcome of Board Meeting - Unaudited Financial Results for the quarter and nine months ended December 31, 2021. (As Per BSE Announcement dated on 28.01.2022) Intimation regarding filing of Form 6k (As per BSE Announcement Dated on 29/01/2022)
Board Meeting - 24-Sep-2021 - -
Quarterly Results Outcome of Board meeting and results of Q2FY22 Intimation (As Per BSE Announcement dated on 29.10.2021)
Board Meeting - 25-Jun-2021 - -
DR.REDDYs LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2021 ,inter alia, to consider and approve the unaudited Financial Results of the Company for the quarter ending on June 30, 2021. Unaudited Financial Results for the quarter ended June 30, 2021 (As Per BSE Announcement Dated on 27.07.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity